Nirsevimab immunisation of infants and respiratory syncytial virus (RSV)-associated hospitalisations, Western Australia, 2024: a population-based analysis

Med J Aust. 2025 Jun 16;222(11):568-570. doi: 10.5694/mja2.52655. Epub 2025 Apr 28.

Lauren E Bloomfield^{1

2}, Nevada V Pingault¹, Rachel E Foong¹, Sarah French¹, Jo-Anne Morgan¹, Ushma Wadia^{3

4}, Hannah C Moore^{4

5}, Christopher C Blyth^{4

6}, Peter C Richmond⁴, Paul K Armstrong¹, Paul V Effler^{1

6}

¹ Western Australia Department of Health, Perth, WA.
² University of Notre Dame Australia, Fremantle, WA.
³ Perth Children's Hospital, Perth, WA.
⁴ Wesfarmers Centre of Vaccine and Infectious Diseases, the Kids Research Institute Australia, Perth, WA.
⁵ Curtin University, Perth, WA.
⁶ University of Western Australia, Perth, WA.

No abstract available

Keywords: Respiratory tract infections; Vaccination; Vaccine preventable disease.